NGOC DURAN: Open Payments
NPI 1487021762 · VICTORIA, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,023 in 60 payments from 13 companies in 2025. Trend: 2023 $520 · 2024 $376 · 2025 $1,023
Food & beverage: $1,023
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 26 | $400 |
| Novo Nordisk Inc | 8 | $138 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $135 |
| PFIZER INC. | 4 | $82 |
| Corium, LLC | 4 | $68 |
| Exact Sciences Corporation | 2 | $48 |
| Amgen Inc. | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $19 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: VRAYLAR, TRINTELLIX, QULIPTA, Wegovy, UBRELVY, Azstarys, NURTEC ODT, OTEZLA.
Industry payments across TX — which companies pay providers there.
